| Medical and Health Sciences | 2021-2025 | 756 | AU 37 | 99.83 |
| Biological Sciences | 2021-2025 | 300 | AU 11 | 99.70 |
| Psychiatry and Mental health | Lifetime | 36 | AU 4 | 99.90 |
| Genetics | Lifetime | 112 | AU 7 | 99.77 |
| Pediatrics, Perinatology and Child Health | Lifetime | 479 | AU 20 | 98.61 |
| Cellular and Molecular Neuroscience | Lifetime | 817 | AU 13 | 96.08 |
| Clinical Biochemistry | Lifetime | 440 | AU 14 | 91.90 |
| Genetics | 2021-2025 | 18 | AU 2 | 99.65 |
| Psychiatry and Mental health | 2021-2025 | 15 | AU 1 | 99.80 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 201 | AU 19 | 96.23 |
| Epilepsy research and treatment | Lifetime | 3 | AU 2 | 99.95 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 10 | AU 2 | 99.89 |
| Genomics and Rare Diseases | Lifetime | 8 | AU 1 | 99.86 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 13 | AU 3 | 99.83 |
| Metabolism and Genetic Disorders | Lifetime | 74 | AU 3 | 99.48 |
| Neuroscience and Neuropharmacology Research | Lifetime | 243 | AU 2 | 99.62 |
| Genomic variations and chromosomal abnormalities | Lifetime | 84 | AU 2 | 99.08 |
| Neonatal and fetal brain pathology | Lifetime | 94 | AU 6 | 99.07 |
| Ion channel regulation and function | Lifetime | 321 | AU 7 | 98.87 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 58 | AU 4 | 97.51 |
| Fetal and Pediatric Neurological Disorders | Lifetime | 458 | AU 11 | 96.24 |
| Ion Transport and Channel Regulation | Lifetime | 517 | AU 14 | 95.74 |
| RNA regulation and disease | Lifetime | 736 | AU 14 | 94.70 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 526 | AU 12 | 92.33 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 743 | AU 26 | 85.21 |
| Tuberous Sclerosis Complex Research | Lifetime | 655 | AU 11 | 81.54 |
| Epilepsy research and treatment | 2021-2025 | 1 | AU 1 | 99.89 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 2 | AU 1 | 99.81 |
| Genomics and Rare Diseases | 2021-2025 | 5 | AU 1 | 99.69 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 4 | AU 1 | 99.59 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 20 | AU 2 | 97.47 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 88 | AU 4 | 97.58 |
| Neonatal and fetal brain pathology | 2021-2025 | 62 | AU 6 | 97.51 |
| Ion channel regulation and function | 2021-2025 | 251 | AU 14 | 89.53 |
| Metabolism and Genetic Disorders | 2021-2025 | 697 | AU 20 | 82.36 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 166 | AU 5 | 74.48 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 203 | AU 6 | 77.12 |
| Fetal and Pediatric Neurological Disorders | 2021-2025 | 718 | AU 14 | 73.96 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 337 | AU 7 | 57.82 |
| Stuttering Research and Treatment | 2021-2025 | 434 | AU 42 | 45.26 |
